Syndax Pharmaceuticals, Inc. (SNDX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 64.86M | 68.48M | 45.87M | 37.96M | 20.04M | 7.68M | 12.5M | 3.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 126.58M | 12.38M | 379K |
| Revenue Growth % | 223.64% | 791.68% | 266.97% | 984.51% | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | 33209.47% | 3165.17% | 0% |
| Cost of Goods Sold | 2.63M | -1.57M | 2.1M | 1.28M | 885K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 121K | 0 | 0 |
| COGS % of Revenue | 4.06% | -2.3% | 4.58% | 3.37% | 4.42% | - | - | - | - | - | - | - | - | - | - | - | - | 0.1% | - | - |
| Gross Profit | 62.23M | 70.05M | 43.77M | 36.68M | 19.16M | 7.68M | 12.5M | 3.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 126.45M | 12.38M | 379K |
| Gross Margin % | 95.94% | 102.3% | 95.42% | 96.63% | 95.58% | 100% | 100% | 100% | - | - | - | - | - | - | - | - | - | 99.9% | 100% | 100% |
| Gross Profit Growth % | 224.85% | 812.15% | 250.17% | 947.97% | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | 33265.44% | 3165.17% | 0% |
| Operating Expenses | 96.43M | 132.6M | 101.2M | 106.03M | 102.91M | 104.05M | 102.08M | 77.72M | 79.51M | 77.91M | 56.35M | 49.68M | 46.02M | 42.03M | 35.14M | 37.72M | 36.86M | 30.83M | 32.41M | 22.71M |
| OpEx % of Revenue | 148.67% | 193.63% | 220.61% | 279.34% | 513.49% | 1354.75% | 816.62% | 2220.46% | - | - | - | - | - | - | - | - | - | 24.35% | 261.87% | 5992.88% |
| Selling, General & Admin | 37.59M | 49.93M | 44.92M | 43.8M | 41.03M | 37.69M | 31.11M | 29.06M | 23.02M | 22.78M | 17.27M | 14.91M | 11.96M | 10.19M | 8.24M | 7.99M | 6.84M | 6.93M | 6.8M | 5.84M |
| SG&A % of Revenue | 57.95% | 72.91% | 97.92% | 115.4% | 204.73% | 490.76% | 248.85% | 830.31% | - | - | - | - | - | - | - | - | - | 5.47% | 54.96% | 1541.42% |
| Research & Development | 58.84M | 78.64M | 56.28M | 62.23M | 61.64M | 65.53M | 70.97M | 48.66M | 56.49M | 55.13M | 39.09M | 34.76M | 34.05M | 31.84M | 26.9M | 29.73M | 30.02M | 23.9M | 25.61M | 16.87M |
| R&D % of Revenue | 90.72% | 114.84% | 122.69% | 163.94% | 307.53% | 853.24% | 567.77% | 1390.14% | - | - | - | - | - | - | - | - | - | 18.88% | 206.92% | 4451.45% |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 247K | 826K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50K |
| Operating Income | -34.2M | -62.55M | -57.43M | -69.35M | -83.76M | -96.36M | -89.58M | -74.22M | -79.51M | -77.91M | -56.35M | -49.68M | -46.02M | -42.03M | -35.14M | -37.72M | -36.86M | 95.75M | -20.03M | -22.33M |
| Operating Margin % | -52.73% | -91.34% | -125.19% | -182.71% | -417.91% | -1254.75% | -716.62% | -2120.46% | - | - | - | - | - | - | - | - | - | 75.65% | -161.87% | -5892.88% |
| Operating Income Growth % | 59.17% | 35.09% | 35.89% | 6.55% | -5.34% | -23.7% | -58.95% | -49.39% | -72.8% | -85.34% | -60.37% | -31.69% | -24.84% | -143.9% | -75.42% | -68.91% | -35.69% | 582.12% | -0.9% | -34.46% |
| EBITDA | -34.2M | -62.55M | -57.42M | -63.99M | -74.62M | -89.36M | -89.58M | -74.21M | -79.51M | -77.9M | -56.35M | -49.67M | -46.01M | -42.03M | -35.13M | -37.71M | -36.85M | 95.87M | -20.02M | -22.23M |
| EBITDA Margin % | -52.73% | -91.33% | -125.18% | -168.58% | -372.31% | -1163.58% | -716.6% | -2120.37% | - | - | - | - | - | - | - | - | - | 75.74% | -161.81% | -5865.17% |
| EBITDA Growth % | 54.16% | 30.01% | 35.89% | 13.78% | 6.15% | -14.71% | -58.96% | -49.4% | -72.8% | -85.35% | -60.4% | -31.72% | -24.87% | -143.84% | -75.45% | -69.66% | -36.24% | 583.24% | -0.98% | -34.01% |
| D&A (Non-Cash Add-back) | 0 | 3K | 3K | 0 | 9.14M | 0 | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 8K | 11K | 11K | 121K | 8K | 105K |
| EBIT | 0 | -15.31M | -52.43M | -63.99M | -92.89M | -89.36M | -84.1M | -68.02M | -72.34M | -72.41M | -51.08M | -44.58M | -41.09M | -39.15M | -33.66M | -36.88M | -36.52M | 96.2M | -19.99M | -22.28M |
| Net Interest Income | 0 | -43.1M | -3.01M | -1.91M | -868K | 2.3M | 5.42M | 6.24M | 7.2M | 5.49M | 5.28M | 5.16M | 5.04M | 2.94M | 33K | 183K | -427K | 91K | -566K | -526K |
| Interest Income | 3.56M | 9.6M | 5.27M | 5.95M | 7.18M | 7.11M | 5.44M | 6.28M | 7.26M | 5.55M | 5.34M | 5.19M | 5.08M | 2.99M | 1.78M | 878K | 224K | 91K | 83K | 108K |
| Interest Expense | -11.85M | 52.7M | 8.28M | 7.86M | 8.05M | 4.81M | 23K | 45K | 55K | 63K | 70K | 35K | 40K | 43K | 1.75M | 695K | 651K | 0 | 649K | 634K |
| Other Income/Expense | -8.47M | -5.47M | -3.29M | -2.49M | -1.09M | 2.2M | 5.45M | 6.15M | 7.11M | 5.43M | 5.21M | 5.06M | 4.89M | 2.84M | -262K | 152K | -311K | 449K | -607K | -576K |
| Pretax Income | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M |
| Pretax Margin % | -65.79% | -99.32% | -132.36% | -189.28% | -423.34% | -1226.16% | -673.01% | -1944.66% | - | - | - | - | - | - | - | - | - | 76% | -166.78% | -6044.85% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M |
| Net Margin % | -65.79% | -99.32% | -132.36% | -189.28% | -423.34% | -1226.16% | -673.01% | -1944.66% | - | - | - | - | - | - | - | - | - | 76% | -166.78% | -6044.85% |
| Net Income Growth % | 49.71% | 27.77% | 27.83% | -5.56% | -17.19% | -29.94% | -64.48% | -52.56% | -76.04% | -84.91% | -44.47% | -18.75% | -10.65% | -140.74% | -71.53% | -64% | -34.07% | 571.03% | -0.99% | -34.27% |
| Net Income (Continuing) | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | -0.78 | -0.70 | -0.83 | -0.99 | -1.10 | -0.98 | -0.80 | -0.85 | -1.00 | -0.73 | -0.64 | -0.59 | -0.62 | -0.58 | -0.62 | -0.63 | 1.81 | -0.40 | -0.44 |
| EPS Growth % | 100% | 29.09% | 28.57% | -3.75% | -16.47% | -10% | -34.25% | -25% | -44.07% | -61.29% | -25.86% | -3.23% | 6.35% | -134.25% | -45% | -40.91% | -16.67% | 511.36% | 13.04% | -4.76% |
| EPS (Basic) | 0.00 | -0.78 | -0.70 | -0.83 | -0.99 | -1.10 | -0.98 | -0.80 | -0.85 | -1.00 | -0.73 | -0.64 | -0.59 | -0.62 | -0.58 | -0.62 | -0.63 | 1.81 | -0.40 | -0.44 |
| Diluted Shares Outstanding | 0 | 86.62M | 86.62M | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 53.18M | 51.96M | 51.6M |
| Basic Shares Outstanding | 0 | 86.62M | 86.62M | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 51.79M | 51.96M | 51.6M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |